Regulating quantal size of neurotransmitter release through a GPCR voltage sensor.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 33046653.
- Also identified by DOI 10.1073/pnas.2005274117 and PMC identifier 7604499.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Current models emphasize that membrane voltage (Vm) depolarization-induced Ca<sup>2+</sup> influx triggers the fusion of vesicles to the plasma membrane. In sympathetic adrenal chromaffin cells, activation of a variety of G protein coupled receptors (GPCRs) can inhibit quantal size (QS) through the direct interaction of G protein Giβγ subunits with exocytosis fusion proteins. Here we report that, independently from Ca<sup>2+</sup>, Vm (action potential) per se regulates the amount of catecholamine released from each vesicle, the QS. The Vm regulation of QS was through ATP-activated GPCR-P2Y<sub>12</sub> receptors. D76 and D127 in P2Y<sub>12</sub> were the voltage-sensing sites. Finally, we revealed the relevance of the Vm dependence of QS for tuning autoinhibition and target cell functions. Together, membrane voltage per se increases the quantal size of dense-core vesicle release of catecholamine via Vm → P2Y<sub>12</sub>(D76/D127) → Giβγ → QS → myocyte contractility, offering a universal Vm-GPCR signaling pathway for its functions in the nervous system and other systems containing GPCRs.
Medical subject headings
- Catecholamines
- Chromaffin Cells
- Heterotrimeric GTP-Binding Proteins
- Secretory Vesicles